Abstract
Tumor necrosis factor-α (TNF-α) has been proposed as an early proximal mediator of many metabolic and physiologic responses during septic shock. We have previously shown that direct addition to tissue (local effect) or intravenous administration (systemic effect) of lipopolysaccharide (LPS) reduces l-leucine absorption across rabbit jejunum. In the present study, we investigated whether the inhibitory effect of LPS on l-leucine intestinal absorption in rabbit is related to TNF-α. The results shown that the addition of TNF-α to tissue does not produce any effect on l-leucine uptake by the enterocyte. When TNF-α was inoculated by intravenous administration, a strong inhibition on the l-leucine uptake (about 40%), mediated by a secretagogue effect on water and Cl-ions was induced. We also found that the LPS intestinal effect induced by intravenous administration, was blocked by a TNF-α antagonist, indicating that TNF-α is a mediator of the LPS systemic effect on l-leucine intestinal uptake inhibition. The study of possible mediators involved in the TNF-α effect showed that nitric oxide and prostaglandins are implicated in the l-leucine intestinal uptake.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Perdue MH, McKay DM: Integrative immunophysiology in the intestinal mucosa. Am J Physiol 267:G151–G165, 1994
Gardiner KR, Ahrendt GM, Gardiner RE, Barbul A: Failure of intestinal amino acid absorptive mechanisms in sepsis. J Am Coll Surg 181:431–436, 1995
Sundaram U, Wisel S, Fromkes JJ: Unique mechanism of inhibition of Na+-amino acid cotransport during chronic ileal inflammation. Am J Physiol 275:G483–G489, 1998
Sundaram U, Coon S, Wisel S, West AB: Corticosteroids reverse the inhibition of Na-glucose cotransport in the chronically inflamed rabbit ileum. Am J Physiol 276:G211–G218, 1999
Damas P, Canivet JL, De Groote D, Vrindts Y, Albert A, Franchiment P, Lamy M: Sepsis and serum cytokine concentrations. Crit Care Med 25:405–412, 1997
Shek PN, Shephard RJ: Physical exercise as a human model of limited inflammatory response. Can J Physiol Pharmacol 76:589–597, 1998
Adams HR: Prostaglandins, related factors, and cytokines. In Veterinary Pharmacology and Therapeutics, 7th ed. HR Adams (ed). Ames, Iowa State University Press, 1995, pp 419–431
Van Dullemen H, Meenan J, Stronkhorst A, Tygat GNJ, Van Deventer SJH: Mediators of mucosal inflammation: Implications for therapy. Scand J Gastroenterol 32(223):92–98, 1997
Bankey P, Carlson A, Ortiz M, Singh R, Cerra F (1990) Tumor Necrosis factor production by kupffer cells requires protein kinase C activation. J Surg Res 49:256–261, 1990
Deem RL, Shanahan F, Targan SR: Triggered human mucosal T cells release TNF-? and IFN-?, which kill human colonic epithelial cells. Clin Exp Immunol 83:79–84, 1991
Gustafson-Svard C, Tagesson C, Boll RM, Kald B: Tumor necrosis factor-alpha potentiates phospholipase A stimulated release and metabolism of arachidonic acid in cultured intestinal epithelial cells (INT 407). Scand J Gastroenterol 28:323–330, 1993
Derkx B, Taminian, Radema S, Stronkhorst A, Wortel C, Tytgat GNJ, Van Deventer SJH: Tumor necrosis factor antibody treatment in Crohn's disease. Lancet 342:173–174, 1993
Steel GR, Torrie HJ: Principles and Procedures in Statistics. New York, McGraw-Hill, 1960
Abad B, Mesonero JE, Salvador MT, Garcia-Herrera J, Rodriguez-Yoldi MJ: Effect of the lipopolysaccharide on small intestinal L-leucine transport in rabbit. Dig Dis Sci 46(5):1113–1119, 2001
Takahashi S, Kapas L, Seyer JM, Wang Y, Krueger JM: Inhibition of tumor necrosis factor attenuates physiological sleep in rabbits. Neuroreport 7(2):642–646, 1996
Mishima S, Xu D, Deitch EA: Increase in endotoxin-induced mucosal permeability in related to increased nitric oxide synthase activity using the Ussing chamber. Crit Care Med 27(5):880–886, 1999
Schmitz H, Fromm M, Bode H, Schulz P, Riecken EO, Schulzke JD: Tumor necrosis factor alpha induces Cl- and K+ secretion in human distal colon driven by prostaglandin E2. Am J Physiol 271:G669–G674, 1996
Hecht G, Koutsouris A: Enteropathogenic E. coli attenuates secretagogue-induced net intestinal ion transport but not Cl- secretion. Am J Physiol 276:G781–G788, 1999
Mourad FH, Turvill JL: Role of nitric oxide in intestinal water and electrolyte transport. Gut 44:143–147, 1999
Izzo AA, Mascolo N, Capasso F: Nitric oxide as a modulator of intestinal water and electrolyte transport. Dig Dis Sci 43(8):1605–1620, 1998
Schirgi-Degen A, Beubler E: Proabsorptive properties of nitric oxide. Digestion 59:400–403, 1998
Powell DW: Immunophysiology of intestinal electrolyte transport In Handbook of Physiology: Intestinal Absorption and Secretion, Vol IV. M Field, RA Frizell (eds). Bethesda, MD, American Physiological Society, 1991, pp 591–641
Nocerino A, Iafusco M, Guandalini S: Cholera toxin-induced small intestinal secretion has a secretory effect on the colon in the rat. Gastroenterology 106:34–39, 1995
Hyun HS, Onaga T, Mineo H, Kato S: Responses of glucose absorption and fructose absorption to prostaglandin E2 in intestinal loops of sheep. Res Vet Sci 62(2):153–157, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Abad, B., Mesonero, J., Salvador, M. et al. Tumor Necrosis Factor-α Mediates Inhibitory Effect of Lipopolysaccharide on l-Leucine Intestinal Uptake. Dig Dis Sci 47, 1316–1322 (2002). https://doi.org/10.1023/A:1015374631385
Issue Date:
DOI: https://doi.org/10.1023/A:1015374631385